First Clinic of Gynecology and Obstetrics, Ataturk Training and Research Hospital, Izmir, Turkey.
Arch Gynecol Obstet. 2009 Dec;280(6):939-44. doi: 10.1007/s00404-009-1038-8. Epub 2009 Mar 21.
The appropriate management of advanced ovarian cancer has been controversial in recent years. Lymphatic node involvement is known one of the most important prognostic factors in epithelial ovarian carcinomas. On the other hand in patients with advanced ovarian cancer involving the upper abdomen (with/without lymph node involvement) the evaluation of pelvic and para-aortic lymph nodes does not contribute to the staging and more importantly it does not improve overall-survival.
One hundred three patients underwent systematic pelvic and para-aortic lymphadenectomy in our clinic. Fifty-three patients with FIGO stage IIIC and IV epithelial ovarian tumor were included in the study. The numbers of positive lymph nodes in each patient were compared with the preoperative CA125 values, positivity/negativity of peritoneal washings and tumor types. Also we compared the patients with positive lymph nodes with patients with negative lymph nodes and investigate differences in CA125 levels, histological types, and cytology.
No significant difference was observed between the patients' preoperative CA125 values and the number of positive lymph nodes. A significant relation was not determined between the positivity or negativity of peritoneal washings and the number of positive lymph nodes. As a number of positive lymph nodes were compared with the tumor types a significant difference was not observed. On the other hand, statistically, a significant relationship was found between patients with positive lymph nodes and patients with negative lymph nodes in terms of preoperative CA125 values, the positivity or negativity of peritoneal washings and histological types of tumors.
We could not determine any effects of preoperative CA125 values, histological type of tumor and peritoneal cytology on the number of positive lymph nodes. Pelvic and para-aortic lymphadenectomy must be performed for us until the factors that affect nodal involvement will be described further in larger and more comprehensive studies.
近年来,晚期卵巢癌的合理治疗一直存在争议。淋巴节受累是上皮性卵巢癌最重要的预后因素之一。另一方面,在涉及上腹部(伴/不伴淋巴结受累)的晚期卵巢癌患者中,盆腔和腹主动脉旁淋巴结的评估对分期没有帮助,更重要的是,它不能提高总生存率。
我们诊所的 103 名患者接受了系统的盆腔和腹主动脉旁淋巴结切除术。53 名 FIGO 分期为 III 期和 IV 期的上皮性卵巢肿瘤患者纳入本研究。比较了每位患者的阳性淋巴结数与术前 CA125 值、腹腔冲洗液的阳性/阴性结果和肿瘤类型。我们还比较了阳性淋巴结患者与阴性淋巴结患者,研究 CA125 水平、组织学类型和细胞学的差异。
患者术前 CA125 值与阳性淋巴结数之间无显著差异。腹腔冲洗液的阳性或阴性与阳性淋巴结数之间也未确定显著关系。将阳性淋巴结数与肿瘤类型进行比较,未观察到显著差异。另一方面,统计学上,阳性淋巴结患者与阴性淋巴结患者在术前 CA125 值、腹腔冲洗液的阳性或阴性以及肿瘤的组织学类型方面存在显著差异。
我们无法确定术前 CA125 值、肿瘤的组织学类型和腹腔细胞学对阳性淋巴结数的影响。在更大和更全面的研究进一步描述影响淋巴结受累的因素之前,我们必须进行盆腔和腹主动脉旁淋巴结切除术。